ACASTI PHARMA INC.
ACASTI PHARMA INC.
Share · CA00430K8656 · ACST · A3EP78 (XNCM)
Overview
No Price
n/a
Company Profile for ACASTI PHARMA INC. Share
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Get up to date insights from finAgent about ACASTI PHARMA INC.

Company Data

Name ACASTI PHARMA INC.
Company Acasti Pharma Inc.
Symbol ACST
Website https://www.acastipharma.com
Primary Exchange XNCM Frankfurt
WKN A3EP78
ISIN CA00430K8656
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Prashant Kohli
Market Capitalization 34 Mio
Country Canada
Currency EUR
Employees 0,0 T
Address 3009 boulevard de la Concorde East, H7E 2B5 Laval
IPO Date 2012-02-07

Ticker Symbols

Name Symbol
Frankfurt A1P0.F
NASDAQ ACST
More Shares
Investors who hold ACASTI PHARMA INC. also have the following shares in their portfolio:
FLUGHAFEN ZüRICH AG
FLUGHAFEN ZüRICH AG Share
TENFU C..CO.LTD
TENFU C..CO.LTD Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025